Peter Neumann, ScD
Scientific Advisor, PHE
Founder and Director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
Professor of Medicine, Tufts University School of Medicine
Dr. Neumann is an internationally recognized thought leader and innovator in the field of health economics and outcomes research, and one of the nation’s foremost experts in the use of cost-effectiveness research in healthcare decision-making. He has conducted numerous economic evaluations of medical technologies, including evaluations of treatments for Alzheimer’s disease. He is also the founder and director of the Cost-Effectiveness Analysis Registry (www.cearegistry.org), a comprehensive database of cost-effectiveness analyses in healthcare. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and has authored more than 200 papers in the medical literature.
ScD, Advancing evidence-based health policy and management, Harvard University
- Cohen JT, et al. A call for open-source cost-effectiveness analysis. Ann Intern Med. 2017.
- Neumann PJ, et al. Cost-effectiveness analysis 2.0. N Engl J Med. 2017.
- Neumann PJ. What next for QALYs? JAMA. 2011.
- Sanders GD, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016.
- Saret CJ, et al. Price and value in cancer care. Cancer. 2015.